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Repairing for death
 
he targets of cytotoxic T lymphocytes
(CTLs) determine their own mode of
death, say Dennis Keefe, Judy Lieber-
man, and colleagues (Harvard Medical School,
Boston, MA). The dying cells patch themselves up
so that rapid and messy necrosis is avoided in
favor of a more lengthy and controlled apoptosis.
The CTLs deliver their insult in the form of
perforin, a pore-forming protein that helps get
proteases called granzymes into the target cell.
The Boston group showed that perforin addition
to a target cell induced a Ca
 
2
 
 
 
 transient and
a massive plasma membrane repair response.
Similar Ca
 
2
 
 
 
-induced responses, in which lyso-
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Perforin induces membrane 
repair that saves cells from 
necrosis.
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somal and other membranes are recruited to patch up plasma membrane
holes, are known to be induced by mechanical damage to cell membranes.
Blocking the rise in Ca
 
2
 
 
 
 and thus the repair response resulted in
far more necrosis. This is presumably a consequence of breaching the
plasma membrane barrier. Necrosis is induced before there is time to
induce the slower process of apoptosis, which tends to sequester intra-
cellular proteins and thus avoid unwanted autoimmune responses.
If the plasma membrane is being repaired, perforin is probably acting
within endosomes to release granzymes into the cytoplasm. The Boston
group gathered more evidence for this theory, but they still want to find
out how perforin induces higher levels of endocytosis, and what changes
within the endosome turn on perforin’s pore-forming activity. 
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Mito immunity
 
itochondria may serve as a surveil-
lance site where innate immune
responses and apoptosis are coor-
dinated, say Rashu Seth, Zhijian Chen, and
colleagues (UTSW, Dallas, Texas). They base
this idea on their discovery of an antiviral
protein that hangs out on mitochondria.
The protein was discovered by three
groups and named MAVS, VISA, and IPS-1.
Overexpression of MAVS (named for its 
 
m
 
ito-
chondrial 
 
a
 
nti
 
v
 
iral 
 
s
 
ignaling) induces interferon
expression and thus increased antiviral defenses.
It operates downstream of RIG-I, which detects
viral double-stranded RNA, but upstream of
the NF-
 
 
 
B and IRF3 families of transcription
factors. RNAi of MAVS abolishes viral acti-
vation of NF-
 
 
 
B and IRF3 and thus knocks out
the antiviral response.
MAVS function requires its transmem-
brane domain, which resembles that of the anti-
apoptosis protein Bcl-2. Both proteins are
found on mitochondria. This puts MAVS closer
to some viruses, which replicate using mem-
branes such as the ER and perhaps mitochon-
dria. It may also allow the coordination of
decisions by the innate immune system and the
apoptosis machinery; some members of the
latter have already been implicated in innate
immunity. Chen suggests that innate immunity
may be just one more service that mitochondria
provide for the cell. 
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MAVS (green) works from mitochondria (red) to direct 
innate immune responses.
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Antiviral walls
 
he innate immune system has the tricky task of foiling all invaders
rather than targeting a specific few. Eugenia Leikina, Leonid
Chernomordik (NICHHD, Bethesda, MD), and colleagues report
that defensin antimicrobial peptides use a unique nonspecific method: they
cross-link surface glycoproteins and thus freeze them in place. The resulting
web of proteins obstructs the fusion of viral and cell membranes.
Defensins caught Chernomordik’s eye because he works on mem-
brane fusion and the defensins have broad specificity. He thought they might
interfere with membrane properties, but was disappointed when they accel-
erated rather than inhibited fusion between protein-free liposomes.
With virus-infected cells, however, things got more interesting. Defensins
did not block virus binding or endocytic uptake but did block membrane fusion.
Membrane glycoproteins no longer diffused over the membrane surface.
The lack of diffusion may be the key. When a virus binds to a cell there is
still a gap of 
 
 
 
10 nm between the membranes, which can be closed only when
proteins in a tiny patch happen, via random diffusion, to get out of the way. With
defensins bound, suggests Chernomordik, “the proteins would not move away.”
“This might be the first natural antiviral agent targeting fusion,” says
Chernomordik. “The fusion stage targeted is elusive, because if proteins are
mobile it is not rate limiting.” He also notes a tantalizing analogy to
prokaryotes, which use covalently cross-linked proteoglycans as a barrier,
forcing bacteriophages to use injection rather than fusion mechanisms. “For a
short time,” he says, “our cells become prokaryotic by erecting these walls.” 
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